在帕金森病中,结合的亚thalamic 核和 globus pallidus internus 深度大脑刺激
M Campins-Romeu1, I Sastre-Bataller1, R Conde-Sardón1
1Hospital Universitario y Politécnico La Fe, Valencia, España.
Revista de neurologia
|July 19, 2023
概括
这项研究探讨了高级帕金森病的综合深度大脑刺激 (DBS). 同时刺激下丘脑核 (STN) 和内球 (GPi) 有效地管理了复杂的运动症状.
科学领域:
- 神经外科 神经外科
- 神经学 神经学
- 运动障碍 运动障碍
背景情况:
- 脑下核 (STN) 和内球 (GPi) 深度大脑刺激 (DBS) 是已确立的治疗高级帕金森病的方法.
- 通常,DBS在相同的大脑结构内双边应用.
- 患有多种运动症状的患者可能会从同时调节不同大脑区域中获益.
研究的目的:
- 报告一个在高级帕金森病患者中结合STN和GPi深度大脑刺激 (DBS) 的病例.
- 为了评估同时,不对称的大脑结构调制对复杂的运动症状的有效性.
主要方法:
- 一名患有晚期帕金森病的患者接受了联合DBS神经外科手术.
- 左侧STN DBS用于管理右侧运动症状.
- 右GPi DBS被用来缓解左侧运动障碍.
主要成果:
- 左侧STN DBS有效控制了右侧帕金森运动症状.
- 右GPi DBS成功地减少了麻烦的左侧运动障碍.
- 综合方法证明了不同症状的成功管理.
结论:
- 结合STN和GPi刺激是晚期帕金森病患者具有复杂运动症状的可行策略.
- 不同的大脑结构的同时调制可以为具有挑战性的病例提供量身定制的解决方案.
更多相关视频
10:52Microelectrode Guided Implantation of Electrodes into the Subthalamic Nucleus of Rats for Long-term Deep Brain Stimulation
Published on: October 2, 2015
19.8K
14:14Targeting Neuronal Fiber Tracts for Deep Brain Stimulation Therapy Using Interactive, Patient-Specific Models
Published on: August 12, 2018
8.9K
相关概念视频
Parkinson's Disease: Treatment
301
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
301
Parkinson's Disease: Overview
601
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
601
